X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (698) 698
Publication (159) 159
Newspaper Article (14) 14
Book / eBook (7) 7
Book Review (7) 7
Book Chapter (5) 5
Conference Proceeding (3) 3
Dissertation (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (295) 295
pharmacology & pharmacy (223) 223
index medicus (217) 217
microbiology (199) 199
microbial sensitivity tests (148) 148
anti-bacterial agents - pharmacology (128) 128
infectious diseases (118) 118
male (118) 118
female (113) 113
middle aged (91) 91
staphylococcus aureus - drug effects (87) 87
vancomycin (87) 87
adult (86) 86
anti-bacterial agents - therapeutic use (72) 72
infections (70) 70
vancomycin - pharmacology (67) 67
aged (65) 65
biochemical phenomena, metabolism, and nutrition (65) 65
daptomycin - pharmacology (62) 62
bacteremia (58) 58
antibiotics (57) 57
staphylococcal infections - microbiology (53) 53
anti-bacterial agents - pharmacokinetics (52) 52
methicillin-resistant staphylococcus aureus - drug effects (52) 52
daptomycin (51) 51
staphylococcal infections - drug therapy (51) 51
animals (47) 47
bacterial infections and mycoses (47) 47
therapy (45) 45
susceptibility (43) 43
endocarditis (42) 42
treatment outcome (42) 42
pharmacokinetics (41) 41
mrsa (40) 40
pharmacology (39) 39
experimental therapeutics (38) 38
methicillin resistance (38) 38
staphylococcus aureus (38) 38
vancomycin resistance (37) 37
anti-bacterial agents - administration & dosage (34) 34
resistance (34) 34
staphylococcus-aureus (34) 34
retrospective studies (33) 33
vancomycin - therapeutic use (33) 33
staphylococcus infections (31) 31
strains (31) 31
drug resistance, bacterial (30) 30
polycyclic compounds (29) 29
time factors (29) 29
vancomycin - pharmacokinetics (29) 29
cephalosporins - pharmacology (28) 28
immunology (28) 28
internal medicine (28) 28
resistant staphylococcus-aureus (28) 28
analysis (27) 27
article (27) 27
drug resistance (27) 27
models, biological (27) 27
care and treatment (26) 26
daptomycin - pharmacokinetics (26) 26
daptomycin - therapeutic use (26) 26
endocarditis, bacterial - microbiology (26) 26
abstracts (25) 25
linezolid (25) 25
mortality (25) 25
prospective studies (25) 25
research (25) 25
combination (24) 24
drug synergism (24) 24
drug therapy, combination (24) 24
endocarditis, bacterial - drug therapy (24) 24
infection (24) 24
aged, 80 and over (23) 23
gram-positive bacterial infections - drug therapy (23) 23
health aspects (23) 23
in-vitro (23) 23
methicillin-resistant staphylococcus aureus (23) 23
pharmacodynamics (23) 23
cohort studies (22) 22
drug resistance, microbial (22) 22
drug therapy (22) 22
medicine & public health (22) 22
risk factors (22) 22
teicoplanin (22) 22
anti-bacterial agents - adverse effects (21) 21
children (21) 21
epidemiology (21) 21
gram-positive bacterial infections - microbiology (21) 21
reduced susceptibility (21) 21
united states (21) 21
bacteria (20) 20
methicillin-resistant staphylococcus aureus - isolation & purification (20) 20
outcomes (20) 20
adolescent (19) 19
enterococcus faecium - drug effects (19) 19
half-life (19) 19
staphylococcus aureus - genetics (19) 19
staphylococcus aureus infections (19) 19
united-states (19) 19
anti-infective agents - pharmacology (18) 18
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (2) 2
Lakeridge Health Sciences - Online (2) 2
Online Resources - Online (2) 2
Scarborough Hospital - General (2) 2
Sunnybrook Health Sciences Centre - Online (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Women's College Hospital - Online (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PHARMACOTHERAPY, ISSN 0277-0008, 08/2015, Volume 35, Issue 8, pp. 755 - 770
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 08/2019, Volume 69, Issue 5, pp. 901 - 902
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 04/2019, Volume 68, Issue Supplement_3, pp. S191 - S192
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 10/2019
Journal Article
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ISSN 1058-4838, 08/2019
Mounting evidence suggests the addition of a beta-lactam (BL) to daptomycin (DAP) results in synergistic in vitro activity against methicillin-resistant... 
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2019, Volume 63, Issue 4
Glycopeptides such as vancomycin have been used as the first-line therapy against MRSA infections for over half a century. Reduced susceptibility and emergence... 
PK/PD | Dalbavancin | Combination therapy | MRSA | STRAINS | VITRO PHARMACOKINETIC/PHARMACODYNAMIC MODEL | ENHANCE DAPTOMYCIN ACTIVITY | VANCOMYCIN-INTERMEDIATE | MICROBIOLOGY | dalbavancin | PLUS DAPTOMYCIN | GLYCOPEPTIDE ANTIBIOTICS | ACUTE BACTERIAL SKIN | PENICILLIN-BINDING PROTEINS | RESISTANCE | combination therapy | PHARMACOLOGY & PHARMACY | BETA-LACTAMS
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 01/2019, Volume 74, Issue 1, pp. 82 - 86
Abstract Background Emergence of reduced susceptibility to vancomycin warrants the development of new antimicrobial agents for the treatment of MRSA. We... 
INFECTIOUS DISEASES | IN-VITRO | ENHANCE DAPTOMYCIN ACTIVITY | VANCOMYCIN PLUS CEFTAROLINE | SYNERGY | ENTEROCOCCUS-FAECALIS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | AGENTS
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2/2011, Volume 52, Issue 3, pp. 285 - 292
Journal Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, ISSN 0066-4804, 08/2019, Volume 63, Issue 8
Multidrug-resistant (MDR) Gram-negative organisms are a major health concern due to lack of effective therapy. Emergence of resistance to newer agents like... 
Klebsiella pneurnoniae | INFECTIONS | EFFICACY | NXL104 | antibiotic combinations | MICROBIOLOGY | PLUS METRONIDAZOLE | MECHANISMS | PHASE-3 | ceftazidime-avibactam | GRAM-NEGATIVE BACTERIA | DOUBLE-BLIND | Pseudomonas aeruginosa | PHARMACOLOGY & PHARMACY | EPIDEMIOLOGY | ENTEROBACTERIACEAE
Journal Article